Long-term survivors of childhood leukemia are at risk for neurocognitive impairment, although the neurophysiological basis is not well understood. The purpose of this study was to explore associations between changes in cerebrospinal fluid (CSF) phospholipids and neurocognitive function in children undergoing chemotherapy for acute lymphoblastic leukemia. Seventy-six children were followed prospectively from diagnosis. CSF samples were collected during scheduled lumbar punctures and phospholipids were extracted. Neurocognitive evaluations were conducted annually beginning shortly after diagnosis. Concentrations of sphingomyelin (SM) increased following induction (p = 0.03) and consolidation (p = 0.04), while lysophosphatidylcholine (LPC) increased following induction (p = 0.003). Multivariable analyses demonstrated associations between post-induction SM and motor speed at 1 year (p < 0.001), 2 years (p = 0.001) and 3 years (p = 0.02) following diagnosis. Post-induction LPC was associated with verbal working memory (p = 0.007). Results indicate that early changes in phospholipids are related to neurocognitive decline and suggest a chemotherapy impact on white matter integrity.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3845091PMC
http://dx.doi.org/10.3109/10428194.2012.717080DOI Listing

Publication Analysis

Top Keywords

phospholipids neurocognitive
12
neurocognitive function
8
acute lymphoblastic
8
lymphoblastic leukemia
8
increased induction
8
0001 years
8
neurocognitive
5
chemotherapy-related changes
4
changes central
4
central nervous
4

Similar Publications

Article Synopsis
  • Sources of milk fat globule membrane (MFGM) are important for infant milk formulas to replicate the benefits of human milk.
  • MFGM naturally contains lipids, proteins, and glycans, which contribute to health areas such as digestion, brain development, and immune function.
  • The review highlights challenges in incorporating MFGM into formulas, including ingredient composition, analytical methods, and effective communication about its benefits.
View Article and Find Full Text PDF

iPLA2β loss leads to age-related cognitive decline and neuroinflammation by disrupting neuronal mitophagy.

J Neuroinflammation

September 2024

National Kunming High-Level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences & Peking Union Medical College, 935 Jiaoling Road, Kunming, 650118, Yunnan, China.

Background: During brain aging, disturbances in neuronal phospholipid metabolism result in impaired cognitive function and dysregulation of neurological processes. Mutations in iPLA2β are associated with neurodegenerative conditions that significantly impact brain phospholipids. iPLA2β deficiency exacerbates mitochondrial dysfunction and abnormal mitochondrial accumulation.

View Article and Find Full Text PDF
Article Synopsis
  • Immune checkpoint inhibitors (ICIs) are effective for treating metastatic melanoma, but about 50% of patients show poor responses, often linked to low HLA-DR levels in tumors.
  • The study highlights how lysophosphatidic acid (LPA), abundant in melanoma, increases IL-10 release and negatively impacts HLA-DR expression through the LPAR1-DR6 pathway.
  • A significant correlation was found between the expression of LPAR1, DR6, and IL-10 in melanoma tissues, suggesting this pathway may contribute to tumor cells' ability to evade immune detection and compromise ICI therapy effectiveness.
View Article and Find Full Text PDF

We have previously reported that, in aortic rings, 18:1 lysophosphatidic acid (LPA) can induce both vasodilation and vasoconstriction depending on the integrity of the endothelium. The predominant molecular species generated in blood serum are poly-unsaturated LPA species, yet the vascular effects of these species are largely unexplored. We aimed to compare the vasoactive effects of seven naturally occurring LPA species in order to elucidate their potential pathophysiological role in vasculopathies.

View Article and Find Full Text PDF

Lipids play crucial roles in the susceptibility and brain cellular responses to Alzheimer's disease (AD) and are increasingly considered potential soluble biomarkers in cerebrospinal fluid (CSF) and plasma. To delineate the pathological correlations of distinct lipid species, we conducted a comprehensive characterization of both spatially localized and global differences in brain lipid composition in App mice with spatial and bulk mass spectrometry lipidomic profiling, using human amyloid-expressing (h-Aβ) and WT mouse brains controls. We observed age-dependent increases in lysophospholipids, bis(monoacylglycerol) phosphates, and phosphatidylglycerols around Aβ plaques in App mice.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!